Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,514,805
+$6,568,337 QoQ
Shares Held
2,585,978
+15.8% QoQ
Ownership
4.14%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. DSGN ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,744,412 | $2,893,664,057 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,799,053 | $2,613,054,769 | |
| 3 | INSM |
INSMED Inc
|
7,421,111 | $1,213,500,070 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,141,701 | $1,121,116,222 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,896,690 | $954,880,319 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
9,555,357 | $929,258,468 | |
| 7 | CELC |
Celcuity Inc.
|
7,915,792 | $903,508,498 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
19,919,186 | $759,319,370 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,514,805 | 2,585,978 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,946,468 | 2,233,099 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,898,001 | 1,712,882 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,772,412 | 1,712,882 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,730,778 | 1,743,725 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,758,783 | 1,743,725 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,381,240 | 1,743,725 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,679,234 | 1,695,294 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,698,343 | 1,662,120 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,975,000 | 1,500,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,540,000 | 1,500,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,150,000 | 500,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,617,120 | 626,884 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,101,264 | 692,131 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,020,553 | 1,436,636 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,112,904 | 1,436,636 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,201,671 | 1,436,636 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,758,376 | 1,436,636 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,104,182 | 1,436,636 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,574,690 | 1,436,636 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $42,955,416 | 1,436,636 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||